WORLD US FDA approves new drug for Alzheimer's in nearly 20 years

WORLD

US FDA approves new drug for Alzheimer's in nearly 20 years

CGTN

08:31, June 08, 2021

This Dec. 10, 2020 file photo shows Food and Drug Administration building in Silver Spring, Md. (Photo: AP)

The U.S. Food and Drug Administration (FDA) approved Aduhelm (aducanumab) on Monday for the treatment of Alzheimer's, the first new medicine against the disease in almost two decades and the first to address cognitive decline linked to the condition.

Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments, according to the FDA.

"Aduhelm is the first treatment directed at the underlying pathophysiology of Alzheimer's disease, the presence of amyloid beta plaques in the brain," said FDA's Patrizia Cavazzoni.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue